George Morrow
Director/Board Member at ALIGN TECHNOLOGY, INC.
Net worth: 2 M $ as of 29/04/2024
George Morrow active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ALIGN TECHNOLOGY, INC. | Director/Board Member | 31/01/2006 | - |
| Independent Dir/Board Member | 08/12/2011 | - | |
| NEUROCRINE BIOSCIENCES, INC. | Director/Board Member | 30/09/2015 | - |
| Independent Dir/Board Member | 30/09/2015 | - |
Career history of George Morrow
Former positions of George Morrow
| Companies | Position | Start | End |
|---|---|---|---|
Vical, Inc.
 Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Director/Board Member | 14/10/2012 | 30/08/2019 |
| Independent Dir/Board Member | 14/10/2012 | 30/08/2019 | |
| OTONOMY | Director/Board Member | 27/04/2015 | 31/05/2018 |
| Independent Dir/Board Member | 27/04/2015 | 31/05/2018 | |
| SAFEWAY INC. | Director/Board Member | 13/05/2013 | - |
| Independent Dir/Board Member | 13/05/2013 | - | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Director/Board Member | 28/02/2011 | - |
| Independent Dir/Board Member | 21/08/2011 | - | |
| AMGEN INC. | Corporate Officer/Principal | 31/12/2002 | 30/01/2011 |
| Sales & Marketing | 31/12/2000 | 31/12/2002 | |
| Glaxo Wellcome, Inc. | Director/Board Member | 31/12/1991 | 31/12/2000 |
| Chief Executive Officer | 31/12/1991 | 31/12/2000 | |
| President | 30/04/1993 | 30/11/2000 | |
| The Fuqua School of Business | Director/Board Member | 31/12/1991 | 31/12/2000 |
| ░░░░░ ░ ░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░ ░░ ░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Training of George Morrow
| Bryn Mawr College | Graduate Degree |
| The Fuqua School of Business | Masters Business Admin |
| Southampton City College | Undergraduate Degree |
| Long Island University | Undergraduate Degree |
| Duke University | Masters Business Admin |
Statistics
International
| United States | 16 |
| United Kingdom | 2 |
Operational
| Director/Board Member | 10 |
| Independent Dir/Board Member | 6 |
| Undergraduate Degree | 2 |
Sectoral
| Health Technology | 9 |
| Consumer Services | 7 |
| Retail Trade | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| ALIGN TECHNOLOGY, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Private companies | 6 |
|---|---|
| Glaxo Wellcome, Inc. | Health Technology |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Health Technology |
Safeway, Inc.
 Safeway, Inc. Food RetailRetail Trade Safeway, Inc. operates a chain of supermarkets. Its services include grocery delivery, gas reward points, pharmacy, deli, simple nutrition, gift cards, money services and floral and gift delivery. The company was founded by M. B. Skaggs in 1915 and is headquartered in Pleasanton, CA. | Retail Trade |
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA. | Health Technology |
| National Commerce Bank |
- Stock Market
- Insiders
- George Morrow
- Experience
